SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Liabilities | ₹2,169 Cr | ₹333 Cr | ₹514 Cr | ₹830 Cr |
What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,169 Cr |
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹830 Cr |
How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,169 Cr | 550.79 | |
| Mar2025 | ₹333 Cr | -35.14 | |
| Mar2024 | ₹514 Cr | -38.11 | |
| Mar2023 | ₹830 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,301.8 Cr | 0.5% | -9.6% | 32.5% | Stock Analytics | |
| PRIME FOCUS | ₹23,542.3 Cr | 8.4% | 5.1% | 93.3% | Stock Analytics | |
| SAGILITY | ₹20,153.1 Cr | 1.4% | -0.5% | -4.5% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,411.2 Cr | 2.4% | -1.8% | -41.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,868.5 Cr | 1.6% | 4.3% | 0.9% | Stock Analytics | |
| INDEGENE | ₹13,573.1 Cr | -0.2% | 10.9% | -4.1% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 0.5% |
-9.6% |
32.5% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses